Autres langues Renovaro Inc. Deutsche Boerse AG

Actions

2Q5

US29350E1047

Marché Fermé - Deutsche Boerse AG Autres places de cotation 08:14:27 31/05/2024			Pré-ouverture 07:33:40
1,316 ^EUR	+0,15%		1,377	+4,64%

24/05	Renovaro et le Centre de cancérologie de l'UMC d'Amsterdam prévoient de former une coentreprise pour l'immunothérapie du cancer	MT
24/05	Renovaro Inc. et l'Amsterdam UMC Cancer Center prêts à faire progresser l'immunothérapie du cancer	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Renovaro, Amsterdam UMC Cancer Center Plan to Form Joint Venture for Cancer Immunotherapy	24/05
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy	24/05
Renovaro Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	15/05
Renovaro's RenovaroCube Amends Agreement to Acquire 100% Stake in Cyclomics	24/04
Renovaro Inc. Announces Geert Kazemier, MD, PhD, as the New Chairman of its Scientific Advisory Board	18/04
Renovaro Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	14/02
Renovaro Inc. Announces Board Changes	14/02
Sector Update: Health Care Stocks Gain Late Afternoon	14/02
Sector Update: Health Care	14/02
Renovaro Shares Jump After Response to Short Seller Hindenburg's Report	14/02
Sector Update: Health Care Stocks Decline Late Afternoon	13/02
Renovaro's GEDi Cube Agrees to Acquire 75% Stake in Cyclomics	13/02
Renovaro Shares Tumble Following Report From Short-Seller Hindenburg	13/02
Renovaro Biosciences Inc. completed the acquisition of GEDi Cube Intl Ltd. for $59.2 million.	13/02
Top Premarket Gainers	07/02
Renovaro Biosciences' Shareholders Approve Share Issuance for Merger Deal With GEDi Cube	25/01
Renovaro Biosciences Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	14/11
Renovaro Biosciences Inc. Appoints Avram Miller as Board of Directors	11/10/23
Renovaro Biosciences Inc. Appoints Leni Boeren and Ruud Hendriks as Independent Directors	10/10/23
Renovaro Biosciences Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	02/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Renovaro Inc. Deutsche Boerse AG

Actions

2Q5

US29350E1047

Autres langues

Filtres